单剂量每日庆大霉素治疗尿路感染。
Single-dose daily gentamicin therapy in urinary tract infection.
作者信息
Labovitz E, Levison M E, Kaye D
出版信息
Antimicrob Agents Chemother. 1974 Oct;6(4):465-70. doi: 10.1128/AAC.6.4.465.
Abstract
Patients with urinary tract infection were treated for 8 to 15 days with one daily intramuscular injection of 160 mg of gentamicin or 60 or 80 mg every 8 h. Ten of 11 patients treated with one injection daily were cured as compared with 8 of 10 patients treated with three injections daily. Urinary concentrations of gentamicin were 3.2 to 600 mug/ml in all 8-h collections in patients receiving one injection daily and were 22 to 440 mug/ml in all 8-h collections in patients receiving three injections daily. The group treated once daily demonstrated a significant but reversible increase in mean serum creatinine concentration and decrease in mean creatinine clearance during therapy as compared with no change in the group treated with three injections daily. Decreases in renal function were correlated with higher milligram per kilogram doses and higher 1-h serum concentrations.
摘要
患有尿路感染的患者接受了8至15天的治疗，每日一次肌肉注射160毫克庆大霉素，或每8小时注射60或80毫克。每日注射一次的11名患者中有10名治愈，而每日注射三次的10名患者中有8名治愈。每日注射一次的患者在所有8小时收集样本中的庆大霉素尿液浓度为3.2至600微克/毫升，每日注射三次的患者在所有8小时收集样本中的庆大霉素尿液浓度为22至440微克/毫升。与每日注射三次的组无变化相比，每日注射一次的组在治疗期间平均血清肌酐浓度显著但可逆地升高，平均肌酐清除率降低。肾功能下降与每千克更高的毫克剂量和更高的1小时血清浓度相关。
相似文献
1
Single-dose daily gentamicin therapy in urinary tract infection.单剂量每日庆大霉素治疗尿路感染。
Antimicrob Agents Chemother. 1974 Oct;6(4):465-70. doi: 10.1128/AAC.6.4.465.
2
[Clinical efficacy and nephrotoxicity of gentamicin in single-dose parenteral administration of total individually adapted daily dosage].
Wien Klin Wochenschr. 1990 May 25;102(11):329-33.
3
[The single daily dose of gentamicin in the treatment of urinary tract infections (author's transl)].
MMW Munch Med Wochenschr. 1980 Feb 8;122(6):212-4.
4
Treatment with a single daily dose of gentamicin in urinary tract infection in relation to the site of infection.每日单次剂量庆大霉素治疗尿路感染与感染部位的关系。
Infection. 1978;6(1):29-31. doi: 10.1007/BF01641088.
5
Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections.比较每日一次和每日三次庆大霉素治疗儿童尿路感染的随机对照试验。
Pediatr Infect Dis J. 2001 Mar;20(3):240-6. doi: 10.1097/00006454-200103000-00004.
6
Single-dose gentamicin therapy of recurrent urinary tract infection in patients with normal urinary tracts.正常尿路患者复发性尿路感染的单剂量庆大霉素治疗
J Pediatr. 1987 Jan;110(1):131-5. doi: 10.1016/s0022-3476(87)80308-6.
7
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.卡芦莫南（Ro 17 - 2301；AMA - 1080）与庆大霉素治疗复杂性尿路感染的比较。
Antimicrob Agents Chemother. 1988 Apr;32(4):473-6. doi: 10.1128/AAC.32.4.473.
8
[Effectiveness and adverse effects of a single daily dose of gentamicin versus twice daily administration].
Lijec Vjesn. 1995 Jan-Feb;117(1-2):33-8.
9
Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.复杂性尿路感染的治疗。西索米星与庆大霉素的对比研究。
Urology. 1977 Jun;9(6):635-8. doi: 10.1016/0090-4295(77)90309-0.
10
Renoprotective role of nifedipine during gentamicin therapy: randomized controlled trial.
Croat Med J. 2000 Dec;41(4):417-22.
引用本文的文献
1
Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate.肾小球滤过率降低患者中阿米卡星的排泄及尿液渗透情况。
Clin Kidney J. 2024 Jan 3;17(1):sfae002. doi: 10.1093/ckj/sfae002. eCollection 2024 Jan.
2
Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules.氨基糖苷类抗生素在革兰氏阴性菌中的摄取、应激和增效作用：老分子的新疗法。
Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0003622. doi: 10.1128/mmbr.00036-22. Epub 2023 Dec 4.
3
Ascorbate and Antibiotics, at Concentrations Attainable in Urine, Can Inhibit the Growth of Resistant Strains of Cultured in Synthetic Human Urine.在尿液中可达到的浓度下，抗坏血酸盐和抗生素能够抑制在合成人尿中培养的耐药菌株的生长。
Antibiotics (Basel). 2023 May 31;12(6):985. doi: 10.3390/antibiotics12060985.
4
Combined Application of Aminoglycosides and Ascorbic Acid in the Elimination of Rods Responsible for Causing Catheter-Associated Urinary Tract Infections (CAUTIs)-A Molecular Approach.氨基糖苷类药物与抗坏血酸联合应用消除致导管相关性尿路感染（CAUTI）棒状菌的分子研究。
Int J Mol Sci. 2022 Oct 28;23(21):13069. doi: 10.3390/ijms232113069.
5
Individualising Therapy to Minimize Bacterial Multidrug Resistance.个体化治疗以最小化细菌的多重耐药性。
Drugs. 2018 Apr;78(6):621-641. doi: 10.1007/s40265-018-0891-9.
6
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae.氨基糖苷类药物用于治疗耐碳青霉烯类肺炎克雷伯菌所致菌血症
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3187-92. doi: 10.1128/AAC.02638-15. Print 2016 May.
7
Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates.基于新型模型的早产儿和足月儿庆大霉素与妥布霉素给药指南
J Antimicrob Chemother. 2015 Jul;70(7):2074-7. doi: 10.1093/jac/dkv052. Epub 2015 Mar 12.
8
Antibiotic-prescribing patterns for Iraqi patients during Ramadan.斋月期间伊拉克患者的抗生素处方模式。
Patient Prefer Adherence. 2014 Nov 26;8:1647-51. doi: 10.2147/PPA.S73401. eCollection 2014.
9
Urinary tract infections in older women: a clinical review.老年女性下尿路感染：临床综述。
JAMA. 2014 Feb 26;311(8):844-54. doi: 10.1001/jama.2014.303.
10
Once-daily aminoglycoside dosing: A new look at an old drug.每日一次氨基糖苷类药物给药：对一种老药的新审视。
Can J Infect Dis. 1994 Sep;5(5):205-6. doi: 10.1155/1994/796138.
本文引用的文献
1
THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS.泌尿道感染的定位与治疗：杀菌尿液水平相对于血清水平的作用
Medicine (Baltimore). 1965 Jan;44:1-36. doi: 10.1097/00005792-196501000-00001.
2
Antibiotic susceptibility testing by a standardized single disk method.采用标准化单纸片法进行抗生素敏感性试验。
Am J Clin Pathol. 1966 Apr;45(4):493-6.
3
Renal insufficiency associated with gentamicin therapy.庆大霉素治疗相关的肾功能不全。
J Infect Dis. 1971 Dec;124 Suppl:S148-55. doi: 10.1093/infdis/124.supplement_1.s148.
4
Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin.假单胞菌属菌血症：庆大霉素治疗失败的药理学及其他原因
J Infect Dis. 1971 Dec;124 Suppl:S185-91. doi: 10.1093/infdis/124.supplement_1.s185.
5
Gentamicin, a new aminoglycoside antibiotic: clinical and laboratory studies in urinary tract infection.庆大霉素，一种新型氨基糖苷类抗生素：尿路感染的临床与实验室研究
J Infect Dis. 1969 Apr-May;119(4):486-91. doi: 10.1093/infdis/119.4-5.486.
6
In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.卡那霉素一种新氨基糖苷衍生物的体外评估，与妥布霉素和庆大霉素的比较。
Antimicrob Agents Chemother. 1973 Apr;3(4):532-3. doi: 10.1128/AAC.3.4.532.
7
Pharmacology of cefazolin in patients with normal and abnormal renal function.
J Infect Dis. 1973 Oct;128:Suppl:S354-7. doi: 10.1093/infdis/128.supplement_2.s354.
8
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素妥布霉素的体外评价
Antimicrob Agents Chemother. 1972 May;1(5):381-4. doi: 10.1128/AAC.1.5.381.
9
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.“广谱”青霉素、头孢菌素及其他抗生素对从菌血症患者中分离出的革兰氏阴性杆菌的抗菌作用。
Ann N Y Acad Sci. 1967 Sep 27;145(2):224-36. doi: 10.1111/j.1749-6632.1967.tb50221.x.
Zotero 插件